Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Group 3 Pulmonary Hypertension
Respiratory Disorder Idiopathic Pulmonary Fibrosis (IPF)
Study results
LPS NCT02951429 Aug2020 French Belgium
(PDF, 0.5 MB)
LPS NCT02951429 Aug2020 Dutch Belgium
(PDF, 0.6 MB)
LPS NCT02951429 Aug2020 English
(PDF, 1.9 MB)
LPS NCT02951429 Aug2020 Arabic Egypt
(PDF, 0.7 MB)
LPS NCT02951429 Aug2020 Greek
(PDF, 0.4 MB)
LPS NCT02951429 Nov2020 Arabic Israel
(PDF, 0.8 MB)
LPS NCT02951429 Nov2020 Hebrew Israel
(PDF, 3.1 MB)
LPS NCT02951429 Nov2020 Russian Israel
(PDF, 0.4 MB)
LPS NCT02951429 Oct2020 Dutch Netherlands
(PDF, 1.0 MB)
LPS NCT02951429 Aug2020 French Canada
(PDF, 1.7 MB)
LPS NCT02951429 Nov2020 Czech
(PDF, 2.0 MB)
LPS NCT02951429 Oct2020 German
(PDF, 0.8 MB)
LPS NCT02951429 Sept2020 Hungarian
(PDF, 0.9 MB)
LPS NCT02951429 Aug2020 Italian
(PDF, 1.2 MB)
LPS NCT02951429 Aug2020 Spanish
(PDF, 0.5 MB)
LPS NCT02951429 Nov2020 Turkey
(PDF, 1.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com